SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-12-107327
Filing Date
2012-03-09
Accepted
2012-03-09 17:24:59
Documents
7
Period of Report
2012-03-07
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d315641d8k.htm 8-K 23814
2 UNDERWRITING AGREEMENT d315641dex11.htm EX-1.1 117120
3 OPINION OF COOLEY LLP d315641dex51.htm EX-5.1 8936
4 PRESS RELEASE d315641dex991.htm EX-99.1 8363
5 PRESS RELEASE d315641dex992.htm EX-99.2 9327
6 GRAPHIC g315641g04f15.jpg GRAPHIC 17162
7 GRAPHIC g315641g63p44.jpg GRAPHIC 7210
  Complete submission text file 0001193125-12-107327.txt   202546
Mailing Address 9360 TOWNE CENTRE DR SUITE 110 SAN DIEGO CA 92121
Business Address 9360 TOWNE CENTRE DR SUITE 110 SAN DIEGO CA 92121 6195522200
AMYLIN PHARMACEUTICALS INC (Filer) CIK: 0000881464 (see all company filings)

IRS No.: 330266089 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19700 | Film No.: 12681714
SIC: 2834 Pharmaceutical Preparations